Lessons learned about community engagement from the past 20 years of HVTN trials informed the success of similar efforts in support of COVID-19 vaccine research. Now that the COVID-19 vaccine studies are reaching their conclusions, what lessons can be applied back to HIV vaccine research as those studies resume? The presenters will share: how the CoVPN built on prior community engagement successes in the HVTN; the success of these efforts in COVID-19 vaccine studies, including enrolment of BIPOC communities; engagement of faith-based organizations and Native American/Indigenous communities; the use of a participant screening registry; and the use of infographics and video for social media and marketing campaigns. As HIV vaccine studies begin to resume, the presenters will also share how these COVID-19 successes are being applied back to HIV research, addressing pre-pandemic challenges with slow study enrolment.

• Presentations
• Session recording (English)